• / Free eNewsletters & Magazine
  • / My Account
Home>Cantrixil Receives Orphan Drug Designation from FDA

Cantrixil Receives Orphan Drug Designation from FDA

3party Content

Wed, 22 Apr 2015

-- Cantrixil receives Orphan Drug Designation in U.S. for ovarian cancerSYDNEY, April 21, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S.
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.